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Periodontitis is an inflammatory disease characterized by destruction of the tooth-supporting tissues. Obese individuals have
an increased risk of periodontitis, and elevated circulating levels of nicotinamide phosphoribosyltransferase (NAMPT) may be
a pathomechanistic link between both diseases. Recently, increased levels of NAMPT have also been found in patients with
periodontitis, irrespective of the presence of obesity.This in vitro study sought to examine the effects of NAMPT on the regenerative
capacity of human periodontal ligament (PDL) cells and, thereby, periodontal healing. PDL cells treated with enamel matrix
derivative (EMD), which was used to mimic regenerative healing conditions in vitro, were grown in the presence and absence
of NAMPT for up to 14 d. EMD stimulated significantly (𝑃 < 0.05) the expression of growth factors and their receptors, matrix
molecules, osteogenesis-associated factors, and wound closure and calcium accumulation. In the presence of NAMPT, all these
stimulatory effects were significantly (𝑃 < 0.05) reduced. In conclusion, the beneficial effects of EMD on a number of PDL cell
functions critical for periodontal regeneration are counteracted by NAMPT. Enhanced levels of NAMPT, as found in obesity and
periodontal inflammation,may compromise the regenerative capacity of PDL cells and, thereby, periodontal healing in the presence
of EMD.
1. Introduction
Periodontitis is a chronicmultifactorial inflammatory disease
that is characterized by the progressive destruction of the
tooth-supporting tissues, such as the periodontal ligament
(PDL). Pathogenic microorganisms embedded in a biofilm
on the tooth surface can trigger local synthesis of proin-
flammatory mediators and matrix-degrading proteases by
infiltrating and resident cells of the periodontium. As a
consequence of the exaggerated immunoinflammatory and
proteolytic processes, the periodontal tissues are subjected to
degradation and resorption, which can result in periodontal
pocket formation and even tooth loss [1–4]. The National
Health and Nutrition Examination Survey III that analyzed
the health and nutritional status in the United States revealed
that approximately half of the US population aged ≥30 years
suffers from periodontitis [5]. It is widely accepted that
periodontitis has a significant negative impact on physical,
psychological, and social aspects of life and also affects
systemic health in affected individuals [6–8].
The main goal of periodontal therapy is to arrest the
inflammatory and tissue-destructive processes by reducing
or eliminating the pathogenic microorganisms in the peri-
odontal pockets [9]. Conventional periodontal treatment
comprises nonsurgical or surgical debridement, sometimes
applied in combination with antibiotics, and achieves peri-
odontal healing mainly by repair [10]. Regenerative healing
can be stimulated by the application of bioactive molecules,
such as enamel matrix derivative (EMD), during periodontal
surgery [11–13]. A great number of in vitro studies have
demonstrated that EMD stimulates the synthesis of growth
factors, such as vascular endothelial growth factor (VEGF)
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and transforming growth factor (TGF) 𝛽1, matrix molecules,
such as collagen type I (COL1) and periostin (POSTN),
osteogenesis-related factors, such as runt-related transcrip-
tion factor (RUNX) 2, calciumdeposition, and in vitrowound
healing [14, 15]. It is widely accepted that the regeneration-
promoting activities of EMD are induced at least in part
by these mechanisms. Moreover, it has been shown that the
beneficial effects of EMD on periodontal regeneration are
mediated, at least partially, by bone morphogenetic protein
(BMP) and TGF𝛽, because fractions of EMD contain BMP-
and TGF𝛽-like activity and EMD stimulates BMP and TGF𝛽
synthesis in periodontal cells [16–19]. Binding of TGF𝛽 and
BMP to their receptor complexes triggers SMAD (sma- and
mad-related protein) and non-SMAD signaling cascades [20,
21].
Regeneration of periodontal tissues is often an unpre-
dictable challenge due to a number of as yet unidentified local
and systemic factors that can modulate healing processes.
Previous studies suggest that microbial, inflammatory, and
biomechanical signals can interfere with the beneficial effects
of EMD on periodontal cells, emphasizing the critical role
of the cell environment for optimal periodontal regeneration
[22–27]. In addition, recent meta-analyses have revealed
that obesity, metabolic syndrome, and diabetes mellitus are
significantly associated with periodontitis, and it has been
suggested that adipokines might be a critical pathomech-
anistic link in these associations [28–31]. Adipokines are
cytokines released from the adipose tissue and regulate food
intake and energy expenditure but also immunoinflamma-
tory processes [32, 33]. Since the serum levels of a number
of proinflammatory adipokines, such as nicotinamide phos-
phoribosyltransferase (NAMPT), are increased in obesity and
some obesity-related diseases, it has been speculated that
such adipokines could enhance periodontal inflammation
and, thereby, increase the risk of periodontitis or compromise
periodontal healing in obese individuals [34–38].
NAMPT is mainly produced by macrophages and
adipocytes in the adipose tissue, triggers NF𝜅B activa-
tion, and elicits synthesis of inflammatory mediators [39].
Increased serum levels of NAMPT have been found in
obesity, metabolic syndrome, type 2 diabetes, atherosclerosis,
and other diseases [34–36]. Therefore, elevated NAMPT
levels could be one mechanism, whereby these diseases
contribute to the initiation and progression of periodonti-
tis. Interestingly, NAMPT is also present at high levels in
gingival crevicular fluid (GCF), gingival tissues, and serum
from patients afflicted with periodontitis, irrespective of the
presence of obesity [40–42]. These observations indicate that
NAMPT is also produced locally in the periodontium and
may play a role in the etiopathogenesis of periodontitis. Our
previous experiments have demonstrated that periodontal
pathogens upregulate NAMPT in periodontal cells and,
additionally, that NAMPT could contribute to periodontal
inflammation and destruction by stimulating periodontal
cells to produce proinflammatory and proteolytic molecules
[43, 44]. However, whether NAMPT also interferes with
periodontal healing is as yet unknown.Therefore, this in vitro
study sought to examine whether the regenerative capacity
of periodontal cells in the presence of EMD is modulated by
NAMPT. A better understanding of the interactions between
regenerative molecules and local as well as systemic factors
may help better predict and even improve the outcome of
currently applied periodontal treatment approaches.
2. Materials and Methods
2.1. Culture and Treatment of Cells. PDL cells from 18 peri-
odontally healthy donors, who underwent tooth extraction
for orthodontic reasons, were used for the experiments.
Informed consent and approval of the Ethics Committee
of the University of Bonn were obtained. The cells were
grown in Dulbecco’s minimal essential medium (DMEM,
Invitrogen, Karlsruhe, Germany) supplemented with 10%
fetal bovine serum (FBS, Invitrogen), 100 units penicillin, and
100 𝜇g/mL streptomycin (Invitrogen) at 37∘C in a humidified
atmosphere of 5% CO
2
. Cells between 3rd and 5th passage
were seeded (50,000 cells/well) on culture plates and grown
to 80% confluence. One day prior to the experiments, the
FBS concentration was reduced to 1%. Medium was changed
every secondday. In order to simulate regenerative conditions
in vitro, PDL cells were treated with EMD (Emdogain,
Straumann, Freiburg, Germany) in the presence and absence
of NAMPT. As in our previous studies, EMDwas applied at a
concentration of 100𝜇g/mL because this concentration had
been used by several investigators before and ensured that
our data were comparable with those of other studies [24–
27]. In order to investigate the effects of NAMPT, various
concentrations of this adipokine (30, 100, and 300 ng/mL;
Biomol, Hamburg, Germany) were added to cells. In our
experiments, the standard concentration of NAMPT was
100 ng/mL.This concentration correlates well with the studies
by Pradeep and coworkers, who have reported a NAMPT
concentration of 98.32 ng/mL in gingival crevicular fluid [40–
42]. However, these studies only included a small num-
ber of patients, so that even higher concentrations can
be expected in some individuals and were therefore also
studied in a subset of our experiments. In the present study,
cells were exposed to EMD and/or NAMPT for up to 14 d
(Figure 1). In order to analyze the intracellular mechanisms
used by NAMPT to modulate the actions of EMD, cells
were preincubated with specific inhibitors against NF𝜅B
(pyrrolidine dithiocarbamate, PDTC; 10 𝜇M; Calbiochem,
San Diego, CA, USA), MEK1/2 (U0126; 10𝜇M; Calbiochem),
JNK (SP600125; 10 𝜇M; Calbiochem), and p38 (SB203580;
10 𝜇M; Calbiochem) signaling pathways 1 h before experi-
ments.
2.2. Real-Time PCR. RNA was extracted by using an RNA
extraction kit (Qiagen, Hilden, Germany), and a total of 1 𝜇g
of RNAwas reverse transcribed using iScriptTMSelect cDNA
Synthesis Kit (Bio-Rad Laboratories, Munich, Germany) at
42∘C for 90min followed by 85∘C for 5min. Expression of
VEGF, TGF𝛽1, and its receptor TGF𝛽R2, BMP receptors
(BMPR1A, BMPR1B, and BMPR2), COL1, POSTN, and
RUNX2 was detected by real-time PCR using the iCycler iQ
detection system (Bio-Rad Laboratories), SYBR Green (Bio-
Rad Laboratories), and specific primers (QuantiTect Primer
Assay, Qiagen) (Figure 1). One 𝜇L of cDNA was amplified as
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Figure 1: Study design flowchart. EMD: enamelmatrix derivative; NAMPT: nicotinamide phosphoribosyltransferase; SMAD: sma- andmad-
related protein; WB: western blot; IF: immunofluorescence; VEGF: vascular endothelial growth factor; TGF𝛽1: transforming growth factor
𝛽1; COL1: collagen type I; POSTN: periostin; RUNX2: runt-related transcription factor 2; BMPR1A, 1B, or 2: bone morphogenetic protein
receptor 1A, 1B, or 2; TGF𝛽R2: TGF𝛽 receptor 2; qPCR: quantitative polymerase chain reaction; ELISA: enzyme-linked immunosorbent assay.
a template in a 25 𝜇L reaction mixture containing 12.5 𝜇L 2x
QuantiFast SYBR Green PCRMaster Mix (Qiagen), 2.5 𝜇L of
primers, and 9 𝜇L deionized water. The mixture was heated
initially at 95∘C for 5min and then followed by 40 cycles
with denaturation at 95∘C for 10 s and combined anneal-
ing/extension at 60∘C for 30 s. Glyceraldehyde-3-phosphate
dehydrogenase was used as an endogenous control. The data
were analyzed by the comparative threshold cycle method.
2.3. ELISA. The protein levels of VEGF and TGF𝛽1 in the
supernatants of PDL cells were analysed by commercially
available enzyme-linked immunosorbent assay (ELISA) kits
(R&D Systems, Minneapolis, MN, USA) according to the
manufacturer’s instructions (Figure 1). The absorbance was
measured by using amicroplate reader (PowerWave x, BioTek
Instruments, Winooski, VT, USA) at 450 nm. The data were
normalized by cell number that was determined with an
automatic cell counter (Moelab, Hilden, Germany).
2.4. Alizarin Red S Staining. The calcium accumulation in
PDL cell cultures following 14 d of treatment with EMD
and/or NAMPT was analyzed by using alizarin red S stain-
ing (Merck KGaA, Darmstadt, Germany) and cetylpyri-
dinium chloride (Sigma-Aldrich Chemie, Munich, Ger-
many), as described in our previous studies (Figure 1) [24,
25]. Briefly, cell monolayers were washed with PBS, fixed in
4% paraformaldehyde (Merck KGaA) for 10min, and washed
again with deionized water. Afterwards, cells were incubated
with 40mM alizarin red S (pH 4.2) for 15min, rinsed
with deionized water, and subsequently incubated with 10%
(w/v) cetylpyridinium chloride in 10mM sodium phosphate
(pH 7.0) in order to extract the alizarin red S that was retained
in the cell cultures. Following 15min of incubation, cells
were detached from the well surface. The detached cells and
cetylpyridinium chloride were collected and centrifuged at
20,000 g for 10min. Afterwards, the pellets were discarded
and the supernatants that contained the extracted stain were
transferred into a 96-well plate to analyze the absorbance at
562 nm using a microplate reader.
2.5. In Vitro Wound Healing. In order to examine the effect
of NAMPT on wound fill, an in vitro wound healing model
was used, as in our previous experiments [24, 25]. Briefly,
cells were grown until confluence and 3mm wide wounds
were created in a standardizedmanner in the cellmonolayers.
The wounded cell monolayers were treated with EMD and,
simultaneously, with various concentrations of NAMPT (0,
30, 100, and 300 ng/mL) for 5 d. At every day, the wounds
were documented by inverse microscopy (Axiovert 25 C,
5x objective, Carl Zeiss, Oberkochen, Germany) and digital
photography (Kodak DC 290, Kodak, Stuttgart, Germany)
(Figure 1). Measurement and analysis of the wound widths
were performed with special software (Alpha DigiDoc 1000,
Alpha Innotech, San Leandro, CA).
2.6. Immunofluorescence. PDL cells were fixed with 4%
paraformaldehyde in PBS pH 7.4 for 10min, washed with
PBS, and treated with 0.1% Triton X-100 (Sigma-Aldrich,
Munich, Germany) for 5min. Then, cells were washed again
and blocked with nonfat dry milk (Bio-Rad Laboratories) for
1 h. After washing, cells were incubated with a rabbit anti-
SMAD1/5/8 antibody (SantaCruz Biotechnology, SantaCruz,
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CA, Germany) for 90min and with CY3-conjugated goat
anti-rabbit IgG (Abcam, Cambridge, MA, USA) for 45min.
Cells were observed under a 20x objective using an Axioplan
2 imagingmicroscope (Carl Zeiss).The images were captured
with a PVCAM camera and the VisiView capturing software
(Visitron Systems, Puchheim, Germany) (Figure 1).
2.7. Western Blot Analysis. Phosphorylation of SMAD1/5/8
was analyzed from whole lysate (20 to 40 𝜇g protein) of
cells treated with EMD in the presence or absence of
NAMPT (Figure 1). Cells werewashed twicewith ice cold PBS
and collected in RIPA buffer (Sigma-Aldrich) supplemented
with protease inhibitors (Sigma-Aldrich). Equal amounts
of protein were resolved through SDS-polyacrylamide gel
electrophoresis and transferred to nitrocellulose membranes
(Bio-Rad Laboratories). The membranes blocked with 5%
nonfat milk were probed with a specific rabbit anti-
pSMAD1/5/8 antibody (Cell Signalling Technology, Dan-
vers, MA, USA). The binding of the primary antibody was
revealed with horseradish peroxidase- (HRP-) labeled goat
anti-rabbit IgG (Jackson ImmunoResearch, Suffolk, UK).
Lightning chemiluminescence reagent (ThermoFisher Scien-
tific, Rockford, IL, USA) was used as an HRP substrate. All
blots were reprobed with rabbit anti-SMAD1/5/8 (Santa Cruz
Biotechnology) and mouse anti-𝛽-actin antibodies (abcam,
Cambridge, UK) to assure equal input of proteins.
2.8. Statistical Analysis. All experiments were performed in
triplicate and repeated at least twice. Mean values and stan-
dard errors of the mean (SEM) were calculated. Parametric
(𝑡 test and ANOVA followed by the post hoc Tukey’s test)
and nonparametric tests (Wilcoxon and Mann-Whitney 𝑈-
tests) were applied for statistical analysis by using the IBM
SPSS Statistics 20 software. Differences between groups were
considered significant at 𝑃 < 0.05.
3. Results
3.1. Regulation of EMD Effects on Growth Factors by NAMPT.
Since the regeneration-promotive effects of EMD are at
least partly mediated by upregulation of growth factors, we
first sought to determine whether these EMD actions on
PDL cells are modulated by NAMPT. As expected from
previous studies, EMD caused a significant upregulation of
VEGF and TGF𝛽1 in PDL cells at 1 d and 3 d. However,
the EMD-stimulated VEGF und TGF𝛽1 expressions were
significantly reduced in the presence of NAMPT at both
time points, as shown in Figures 2(a) and 2(b). Interestingly,
NAMPT did not induce a significant downregulation of the
constitutive VEGF and TGF𝛽1 expressions (Figures 2(a) and
2(b)). Dose response experiments revealed that the inhibitory
effects of NAMPT on the EMD-stimulated VEGF and TGF𝛽1
upregulationwere similar over awide range of concentrations
(Figures 2(c) and 2(d)). By preincubation of cells with a
specific inhibitor against the JNK signaling pathway, the
inhibitory effects of NAMPT on the EMD-induced VEGF
and TGF𝛽1 expressions were completely blocked at 1 d.
However, inhibition of NF𝜅B, MEK1/2, or p38 signaling did
Table 1: Regulation of VEGF and TGF𝛽1 protein syntheses by
EMD and/or NAMPT (100 ng/mL) after 3 d, as analyzed by ELISA.
Untreated cells served as control. Mean ± SEM (n = 12); ∗signifi-
cantly (𝑃 < 0.05) different from all other groups.
Group VEGF(ng/106 cells)
TGF𝛽1
(ng/106 cells)
Control 1.68 ± 0.08 2.08 ± 0.01
EMD 3.88 ± 0.32∗ 3.39 ± 0.11∗
NAMPT 1.73 ± 0.01 1.68 ± 0.02
EMD + NAMPT 3.07 ± 0.34 2.78 ± 0.06
not interfere with the actions of NAMPT at this time point
(data not shown).
The inhibitory effects of NAMPT on the EMD-stimulated
VEGF and TGF𝛽1 expressions were also found at protein
level, as analyzed by ELISA after 3 d (Table 1).
3.2. Modulation of EMD Actions on Matrix Molecules by
NAMPT. EMD also stimulates periodontal regeneration by
upregulation of matrix molecules.Therefore, we next studied
whether actions of EMD on matrix molecules are modulated
by NAMPT. EMD increased significantly the expression of
COL1 and POSTN at 1 d and 3 d, but these stimulatory effects
were significantly inhibited by NAMPT for COL1 at 1 d and
for POSTN at 1 d and 3 d (Figures 2(e) and 2(f)). NAMPT had
no regulatory effects on the spontaneous expression of COL1
and POSTN (Figures 2(e) and 2(f)).
3.3. Effects of NAMPT on EMD-Stimulated Mineralization.
Next, we wondered whether NAMPT would also interfere
with the stimulatory effects of EMD on osteogenesis. As
expected, EMD stimulated significantly the expression of
RUNX2, an osteogenesis-associated transcription factor, at
1 d and 3 d (Figure 3(a)). Interestingly, the EMD-induced
RUNX2 expression was also significantly downregulated by
NAMPT, which reached significance at 1 d (Figure 3(a)).
Furthermore, treatment of cells with EMD for 14 d caused
a pronounced calcium accumulation in cell cultures, as
determined by alizarin red S staining (Figures 3(b) and
3(c)). When cells were simultaneously treated with EMD and
NAMPT, the calcium accumulation was significantly reduced
as compared to EMD-stimulated cultures in the absence of
NAMPT (Figures 3(b) and 3(c)).
3.4. Effects of NAMPT on EMD-Induced Wound Healing.
NAMPT also caused a dose-dependent inhibition of the
EMD-stimulated wound healing (Figure 4(a)). The EMD-
induced wound closure was significantly reduced by 100 ng/
mL of NAMPT and even more pronounced by 300 ng/mL of
NAMPT at 3, 4, and 5 d, whereas 30 ng/mL of NAMPT had
only a significantly inhibitory effect at 5 d (Figure 4(a)).
3.5. Effects of NAMPT on BMPRs and TGF𝛽Rs in the Pres-
ence and Absence of EMD. At least some actions of EMD
seem to be mediated by BMP or TGF𝛽 because EMD
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Figure 2: Effect of EMD on the VEGF (a), TGF𝛽1 (b), COL1 (e), and POSTN (f) mRNA expressions in the presence and absence of NAMPT
(100 ng/mL) at 1 d and 3 d. Untreated cells served as control. All experiments were performed in triplicate and repeated at least twice. Mean
± SEM (𝑛 = 18); ∗significant (𝑃 < 0.05) difference between groups. Effect of various concentrations (0, 30, 100, and 300 ng/mL) of NAMPT
on the VEGF (c) and TGF𝛽1 (d) mRNA expressions in EMD-treated cells at 1 d. All experiments were performed in triplicate and repeated
at least twice. Mean ± SEM (𝑛 = 9).
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Figure 3: Effect of EMD on the RUNX2 (a) mRNA expression in the presence and absence of NAMPT (100 ng/mL) at 1 d and 3 d. Untreated
cells served as control. All experiments were performed in triplicate and repeated at least twice. Mean ± SEM (𝑛 = 18); ∗significant (𝑃 < 0.05)
difference between groups. Effect of EMD on the calcium accumulation in the presence and absence of NAMPT (100 ng/mL) in cultures of
PDL cells ((b) and (c)). Untreated cells served as control. The calcium accumulation was analysed by alizarin red S staining, visualized by
microscopy (c), and quantified by elution with cetylpyridinium chloride (b) at 14 d. All experiments were performed in triplicate and repeated
at least twice. Mean ± SEM (𝑛 = 12); ∗significant (𝑃 < 0.05) difference between groups. Images from one representative donor are shown.
has been shown to possess BMP- and TGF𝛽-like activity
and, additionally, to upregulate these molecules in peri-
odontal cells. We therefore also examined the effects of
NAMPT on BMPRs and TGF𝛽Rs. As shown in Figure 4(b),
EMD increased significantly the constitutive expression of
BMPR1A, BMPR1B, BMPR2, and TGF𝛽R2 at 1 d. However,
NAMPT caused a significant downregulation of the EMD-
stimulated expression of these receptors at this time point
(Figure 4(b)). Similar results were found for 3 d (data not
shown). In the absence of EMD, a significant inhibition by
NAMPT was only found for BMPR1A (Figure 4(b)).
3.6. Inhibition of SMAD Signaling by NAMPT in EMD-
Treated Cells. Next, we sought to unravel intracellular mech-
anisms, whereby NAMPT abrogates regeneration-promotive
actions of EMD. As shown in Figure 5(a), EMD caused
a pronounced accumulation of SMAD1/5/8 in the nucleus
of EMD-treated cells at 60min. However, in the presence
of NAMPT, this EMD-stimulated nuclear translocation of
SMAD1/5/8 was reduced. In the absence of EMD, no obvious
effect of NAMPT on the SMAD1/5/8 nuclear translocation
was observed (Figure 5(a)). Further experiments revealed
that EMD stimulated the phosphorylation of SMAD1/5/8 in
Mediators of Inflammation 7
1 2 3
Time (d)
4 5
W
ou
nd
 fi
ll 
(%
)
EMD
0
20
40
60
80
100
EMD + NAMPT (30 ng/mL)
EMD + NAMPT (100 ng/mL)
EMD + NAMPT (300 ng/mL)
∗
∗
∗
∗
∗
∗
∗
(a)
0.0
1.0
1.5
2.5
3.0
4.0
0.5
2.0
3.5
m
RN
A
 ex
pr
es
sio
n 
(fo
ld
 o
f c
on
tro
l) BMPR1A BMPR1B4.5 BMPR2 TGF𝛽R2
EMD
NAMPT
++ −++ −
+ + + +
−−
− − − −
++ −++ −
+ + + +
−−
− − − −
∗
∗∗∗∗∗
∗
∗
∗
∗∗∗∗∗
∗
∗
1 d
(b)
Figure 4: Effect of various concentrations (0, 30, 100, and 300 ng/mL) of NAMPT on the EMD-induced PDL cell wound fill rate (a). The
wound closure, that is, the percentage of fill of the initially cell free zones created by wounding, were analysed over 5 d. All experiments were
performed in triplicate and repeated at least twice. Mean ± SEM (𝑛 = 12); ∗significantly (𝑃 < 0.05) different from EMD-treated cells in the
absence of NAMPT. Effect of EMD on the expression of BMPR1A, BMPR1B, BMPR2 and TGF𝛽R2 in the presence and absence of NAMPT
(100 ng/mL) at 1 d (b). Untreated cells served as control. All experiments were performed in triplicate and repeated at least twice. Mean ±
SEM (𝑛 = 18); ∗significant (𝑃 < 0.05) difference between groups.
a time-dependent manner, as evidenced by immunoblotting
(Figure 5(b)). As shown in Figure 5(c), the EMD-stimulated
SMAD1/5/8 phosphorylation was inhibited in the presence of
NAMPT.
4. Discussion
The present study demonstrates for the first time that
regeneration-promotive actions of EMD on a great number
of PDL cell functions critical for periodontal regeneration are
jeopardized by NAMPT. The findings of this study suggest
that increased levels of NAMPT, as found in obesity and
periodontal inflammation, may compromise the regenerative
capacity of PDL cells and, thereby, periodontal healing in the
presence of EMD.
NAMPT abrogated the stimulatory effects of EMD on
VEGF and TGF𝛽1, COL1, in vitro wound healing, and
osteogenic differentiation.VEGF is an essential growth factor,
which supports wound healing by its regulatory effects on
vascular permeability, influx of inflammatory cells into the
site of injury, migration and proliferation of preexisting
endothelial cells, and the recruitment of marrow-derived
endothelial progenitor cells to the local wound site [45]. In
addition, VEGF seems to play an important role in the mod-
ulation of bone remodeling by attracting endothelial cells and
osteoclasts and by stimulating osteoblast differentiation [46].
TGF𝛽, another important growth factor, comprises three
isoforms and also promoteswoundhealing likeVEGF.TGF𝛽1
supportsmigration of wound keratinocytes and, thereby, suc-
cessful reepithelialization [47]. Moreover, it induces fibrob-
lasts to deposit new extracellular matrix proteins, which
promotes cell and vascular in-growth [48]. In addition to
growth factors, matrix molecules, such as COL1 and POSTN,
are also critical for periodontal homeostasis and healing. Like
COL1, POSTN is also strongly expressed in the human PDL
and regulates cell-matrix interactions as well as cell adhe-
sion, proliferation, and differentiation [49, 50]. Furthermore,
periostin also aids to disperse mechanical forces applied to
the PDL [50, 51]. Interestingly, NAMPT also counteracted the
stimulatory effects of EMD on the in vitro wound healing.
Following periodontal treatment, periodontal wounds need
to be repopulated with cells to achieve periodontal healing
[52]. When EMD-treated cells were exposed to NAMPT, the
wound closurewas dose-dependently delayed, indicating that
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Figure 5: Effect of EMD on the nuclear translocation of SMAD1/5/8 in the presence and absence of NAMPT (100 ng/mL) at 60min, as
determined by immunofluorescence (a). Untreated cells served as control. Stimulation of SMAD1/5/8 phosphorylation by EMD over 60min,
as analyzed by immunoblotting (b). Effect of EMD on SMAD1/5/8 phosphorylation in the presence and absence of NAMPT (100 ng/mL) at
60min, as examined by immunoblotting (c). All experiments were performed in triplicate and repeated at least twice. Images and blots from
one representative donor are shown.
NAMPT may also inhibit critical cell functions, such as pro-
liferation andmigration, under regenerative conditions. PDL
cells can acquire an osteoblastic phenotype, and a number
of studies have proven that EMD stimulates expression of
osteogenesis-associated factors, such as RUNX2, and calcium
deposition, an early marker of matrix mineralization, from
PDL cells [14]. As expected, EMD upregulated RUNX2 and
induced calcium deposition in the present study. In the
presence of NAMPT, the stimulatory effects of EMD on
these osteogenesis-related processes were reduced. Although
NAMPT inhibited significantly the EMD-induced RUNX2
and collagen expressions at 1 day, the inhibitory effects
of NAMPT did not reach significance at 3 days due to
the pronounced standard deviations. However, including a
higher number of donors in these experiments might have
resulted in statistically significant changes also at 3 days.
Nevertheless, our findings suggest that NAMPT interferes
with both the EMD-induced effects on both periodontal soft
and hard tissue regeneration.
We also sought to unravel the mechanisms, whereby
NAMPT modulates the actions of EMD. Fractions of EMD
contain BMP- and TGF𝛽-like activity and EMD also upregu-
lates BMP and TGF𝛽 in periodontal cells [16–19]. Therefore,
it is thought that beneficial effects of EMD on periodontal
regeneration are mediated, at least in part, by these factors.
We therefore studied whether NAMPT regulates the expres-
sion of their receptors as a possible mechanism, whereby
NAMPT may modulate the actions of EMD. BMP binds to
BMPR1, uponwhich BMPR2 is recruited into the complex, or
binds to a preformed complex of BMPR1 and BMPR2, which
triggers the activation of SMAD and non-SMAD pathways
[21]. Following binding of TGF𝛽 to TGF𝛽R2, TGF𝛽R1 is
recruited into a heterotetrameric receptor complex and then
phosphorylated on serine residues by TGF𝛽R2, which also
finally results in the activation of the SMAD signaling
pathway [20]. As shown in the present and our previous
studies, PDL cells express receptors for BMP and TGF𝛽 [24–
26]. EMD increased the constitutive expression of BMPRs
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and TGF𝛽Rs, and this EMD-stimulated receptor upregu-
lation was inhibited by NAMPT. These findings suggest
that NAMPT can regulate actions of EMD also at receptor
level, as it has recently been shown for interleukin-1𝛽 and
biomechanical forces [24–26].
Furthermore, we sought to identify intracellular mecha-
nisms,whereby the stimulatory effects of EMDaremodulated
by NAMPT. Our experiments revealed that the inhibition
of the EMD-induced VEGF and TGF𝛽1 upregulation by
NAMPT was JNK-dependent. Moreover, NAMPT inhib-
ited the EMD-stimulated phosphorylation of SMADs and,
additionally, inhibited their nuclear translocation. Further
experiments are needed to clarify how JNK interferes with
SMAD signaling and whether additional signaling pathways
are involved.
The present study also confirms our previous studies on
the harmful effects of inflammatory signals on regenerative
periodontal healing [24–26]. Moreover, in the present study,
we provide original evidence that also systemic factors,
such as NAMPT, whose levels are increased in obesity,
metabolic syndrome, and diabetes mellitus, may interfere
with periodontal healing. Although PDL cells are of utmost
importance in periodontal regenerative healing, in a clin-
ical setting, additional cells, such as inflammatory cells,
keratinocytes, gingival fibroblasts, and osteo- and cemento-
blasts, are involved. Further studies should examine whether
NAMPT also affects these cells under normal and regenera-
tive conditions. Moreover, in addition to NAMPT, the levels
of other adipokines, such as leptin, resistin, and adiponectin,
are altered in obesity and periodontal inflammation [53–
56]. Future studies should therefore focus on the regulation
of periodontal cells and their regenerative capacity by these
adipokines.
In summary, the present study shows for the first time that
beneficial effects of EMD on a number of PDL cell functions
critical for periodontal regeneration are counteracted by
NAMPT. Enhanced levels of NAMPT, as found in obesity and
periodontal inflammation, may compromise the regenerative
capacity of PDL cells and, thereby, regenerative periodontal
healing in the presence of EMD.
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